MARÍA ISABEL
BLANCAS LÓPEZ-BARAJAS
PROFESORA ASOCIADA LABORAL
Hospital Universitario de Valme
Sevilla, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario de Valme (4)
2024
-
Retrospective registry of patients with locally advanced/metastatic HR+/HER2− breast cancer treated in clinical practice in Andalusia
Clinical and Translational Oncology
2018
-
Correction to: Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice (Clinical and Translational Oncology, (2018), 20, 7, (862-869), 10.1007/s12094-017-1797-9)
Clinical and Translational Oncology
-
Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice
Clinical and Translational Oncology, Vol. 20, Núm. 7, pp. 862-869
2014
-
Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
Clinical and Translational Oncology, Vol. 17, Núm. 2, pp. 160-166